amikacin has been researched along with Acute Symptom Flare in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilton, D; Cipolli, M; Clancy, JP; Eagle, G; Fajac, I; Galeva, I; Gupta, R; Konstan, MW; Liu, K; McGinnis, JP; Minic, P; Pressler, T; Quittner, AL; Sands, D; Solé, A | 1 |
| Marsot, A; Matouk, E; Pasche, V; Thirion, DJG | 1 |
1 trial(s) available for amikacin and Acute Symptom Flare
| Article | Year |
|---|---|
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Liposomes; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Surveys and Questionnaires; Symptom Assessment; Symptom Flare Up; Tobramycin; Treatment Outcome | 2020 |
1 other study(ies) available for amikacin and Acute Symptom Flare
| Article | Year |
|---|---|
Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Models, Biological; Nomograms; Symptom Flare Up; Young Adult | 2020 |